MyChesCo on MSN4d
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
Press Release The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma ...
Mena FN1mon
Sterile Injectable Drugs Market To Expand Significantly, Projected To Achieve USD 1470.3 Billion By 2033
The Sterile Injectable Drugs Market was valued at USD 596.2 billion in 2023. It is expected to reach USD 1470.3 billion by 2033, with a CAGR of 9.7% In 2023, Cardiovascular Diseases held a ...